Evidence map›Paper›PMID 41584033›Full record

ArticleJournal of Cancer2026

Targeting Dermatologic Side Effects of Immunotherapy Using Novel Skin Care Products.

Marithé Claes, Joy Lodewijckx, Jolien Robijns, Laura Tuts, Melissa Lenaerts, Eline Vandaele, Tim Wessels, Annelies Requilé, Daisy Luyten, Yolanda Verheezen and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of Cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Marithé ClaesHasselt University, Faculty of Medicine and Life Sciences, Agoralaan, 3590 Diepenbeek, Belgium / LCRC.
Joy LodewijckxHasselt University, Faculty of Medicine and Life Sciences, Agoralaan, 3590 Diepenbeek, Belgium / LCRC.
Jolien RobijnsHasselt University, Faculty of Medicine and Life Sciences, Agoralaan, 3590 Diepenbeek, Belgium / LCRC.
Laura TutsHasselt University, Faculty of Medicine and Life Sciences, Agoralaan, 3590 Diepenbeek, Belgium / LCRC.
Melissa LenaertsHasselt University, Faculty of Medicine and Life Sciences, Agoralaan, 3590 Diepenbeek, Belgium / LCRC.
Eline VandaeleHasselt University, Faculty of Medicine and Life Sciences, Agoralaan, 3590 Diepenbeek, Belgium / LCRC.
Tim WesselsJessa Hospital, Dept. Medical Oncology and Dept. Jessa & Science, Salvatorstraat 20, 3500 Hasselt, Belgium / LCRC.
Annelies RequiléJessa Hospital, Dept. Medical Oncology and Dept. Jessa & Science, Salvatorstraat 20, 3500 Hasselt, Belgium / LCRC.
Daisy LuytenJessa Hospital, Dept. Medical Oncology and Dept. Jessa & Science, Salvatorstraat 20, 3500 Hasselt, Belgium / LCRC.
Yolanda VerheezenJessa Hospital, Dept. Medical Oncology and Dept. Jessa & Science, Salvatorstraat 20, 3500 Hasselt, Belgium / LCRC.
Eric JoosensJessa Hospital, Dept. Medical Oncology and Dept. Jessa & Science, Salvatorstraat 20, 3500 Hasselt, Belgium / LCRC.
Jeroen MebisHasselt University, Faculty of Medicine and Life Sciences, Agoralaan, 3590 Diepenbeek, Belgium / LCRC.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

canceremollientimmunotherapyoncologyquality of lifeskin careskin toxicity

Identifiers

PMID41584033
PMCPMC12825116

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.